XWELL EBITDA Margin 2010-2025 | XWEL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for XWELL (XWEL) over the last 10 years. The current EBITDA margin for XWELL as of June 30, 2025 is .
| XWELL EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $0.03B | $-0.02B | -53.33% |
| 2025-03-31 | $0.03B | $-0.02B | -48.39% |
| 2024-12-31 | $0.03B | $-0.01B | -42.42% |
| 2024-09-30 | $0.03B | $-0.01B | -15.15% |
| 2024-06-30 | $0.03B | $-0.01B | -37.50% |
| 2024-03-31 | $0.03B | $-0.02B | -48.39% |
| 2023-12-31 | $0.03B | $-0.02B | -62.07% |
| 2023-09-30 | $0.03B | $-0.03B | -106.67% |
| 2023-06-30 | $0.03B | $-0.03B | -79.41% |
| 2023-03-31 | $0.04B | $-0.03B | -72.50% |
| 2022-12-31 | $0.06B | $-0.03B | -43.86% |
| 2022-09-30 | $0.08B | $-0.01B | -12.82% |
| 2022-06-30 | $0.09B | $0.00B | 4.26% |
| 2022-03-31 | $0.09B | $0.01B | 7.87% |
| 2021-12-31 | $0.07B | $0.01B | 10.81% |
| 2021-09-30 | $0.05B | $-0.01B | -26.67% |
| 2021-06-30 | $0.02B | $-0.03B | -150.00% |
| 2021-03-31 | $0.01B | $-0.03B | -344.44% |
| 2020-12-31 | $0.01B | $-0.03B | -400.00% |
| 2020-09-30 | $0.02B | $-0.02B | -126.32% |
| 2020-06-30 | $0.03B | $-0.02B | -46.88% |
| 2020-03-31 | $0.05B | $-0.01B | -20.00% |
| 2019-12-31 | $0.05B | $-0.01B | -16.33% |
| 2019-09-30 | $0.05B | $0.00B | -4.00% |
| 2019-06-30 | $0.05B | $-0.01B | -10.00% |
| 2019-03-31 | $0.05B | $-0.01B | -10.00% |
| 2018-12-31 | $0.05B | $-0.01B | -13.73% |
| 2018-09-30 | $0.05B | $-0.01B | -9.80% |
| 2018-06-30 | $0.05B | $-0.01B | -11.76% |
| 2018-03-31 | $0.05B | $-0.01B | -11.76% |
| 2017-12-31 | $0.05B | $-0.01B | -14.29% |
| 2017-09-30 | $0.03B | $0.01B | 15.63% |
| 2017-06-30 | $0.02B | $-0.01B | -31.82% |
| 2017-03-31 | $0.02B | $0.00B | -15.00% |
| 2016-12-31 | $0.01B | $0.00B | -18.18% |
| 2016-09-30 | $0.04B | $0.00B | 7.69% |
| 2015-12-31 | $0.02B | $0.00B | -17.39% |
| 2015-03-31 | $0.00B | $-0.04B | -3700.00% |
| 2014-12-31 | $0.00B | $-0.04B | -4000.00% |
| 2014-03-31 | $0.00B | $-0.04B | -3500.00% |
| 2013-06-30 | $0.00B | $-0.03B | -3300.00% |
| 2011-06-30 | $0.00B | $-0.01B | 0.00% |
| 2011-03-31 | $0.00B | $-0.01B | 0.00% |
| 2010-12-31 | $0.00B | $-0.01B | 0.00% |
| 2010-06-30 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.006B | $0.034B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.660B | 28.13 |
| CVS Health (CVS) | United States | $90.432B | 11.25 |
| Elevance Health (ELV) | United States | $71.280B | 9.59 |
| Cencora (COR) | United States | $56.729B | 18.89 |
| DiDi Global (DIDIY) | China | $27.580B | 29.30 |
| Labcorp Holdings (LH) | United States | $23.117B | 18.37 |
| Natera (NTRA) | United States | $22.728B | 0.00 |
| BioMerieux (BMXMF) | France | $17.547B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.699B | 0.00 |
| ICON (ICLR) | Ireland | $14.200B | 13.66 |
| Medpace Holdings (MEDP) | United States | $13.025B | 34.47 |
| CochLear (CHEOY) | Australia | $12.814B | 0.00 |
| Solventum (SOLV) | United States | $12.753B | 13.16 |
| Viatris (VTRS) | United States | $12.417B | 4.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $11.052B | 0.00 |
| Revvity (RVTY) | United States | $10.928B | 19.25 |
| Avantor (AVTR) | United States | $9.047B | 13.27 |
| Sonic Healthcare (SKHHY) | Australia | $8.007B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.965B | 15.11 |
| HealthEquity (HQY) | United States | $7.767B | 34.02 |
| Bausch + Lomb (BLCO) | Canada | $5.289B | 35.57 |
| Sotera Health (SHC) | United States | $4.667B | 26.08 |
| BrightSpring Health Services (BTSG) | United States | $4.406B | 33.61 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.82 |
| KindlyMD (NAKA) | United States | $3.810B | 0.00 |
| GeneDx Holdings (WGS) | United States | $3.696B | 84.65 |
| Alignment Healthcare (ALHC) | United States | $3.137B | 0.00 |
| Concentras Parent (CON) | United States | $3.031B | 19.23 |
| Surgery Partners (SGRY) | United States | $3.031B | 38.13 |
| Organon (OGN) | United States | $2.451B | 2.67 |
| Premier (PINC) | United States | $2.070B | 19.19 |
| Progyny (PGNY) | United States | $2.023B | 42.78 |
| Ardent Health (ARDT) | United States | $1.858B | 7.17 |
| PACS (PACS) | United States | $1.836B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.584B | 26.82 |
| Pediatrix Medical (MD) | United States | $1.481B | 9.89 |
| Teladoc Health (TDOC) | United States | $1.357B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.264B | 0.00 | |
| Omada Health (OMDA) | $1.227B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.841B | 4.92 |
| AMN Healthcare Services Inc (AMN) | United States | $0.795B | 9.83 |
| CareDx (CDNA) | United States | $0.690B | 12.72 |
| QDM (QDMI) | Hong Kong, SAR China | $0.641B | 110.00 |
| Performant Healthcare (PHLT) | United States | $0.599B | 0.00 |
| Agilon Health (AGL) | United States | $0.551B | 0.00 |
| Nutex Health (NUTX) | United States | $0.513B | 7.77 |
| InnovAge Holding (INNV) | United States | $0.505B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.501B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.457B | 6.87 |
| SBC Medicals (SBC) | United States | $0.444B | 9.75 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.442B | 0.00 |
| Enhabit (EHAB) | United States | $0.415B | 27.30 |
| So-Young (SY) | China | $0.411B | 0.00 |
| Oncology Institute (TOI) | United States | $0.338B | 0.00 |
| LifeMD (LFMD) | United States | $0.300B | 0.00 |
| Beauty Health (SKIN) | United States | $0.280B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.194B | 0.00 |
| DocGo (DCGO) | United States | $0.168B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.145B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| ModivCare (MODV) | United States | $0.015B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |